| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.352 | 0.862 | 1.8E-03 |
|
group | 0.300 | 40 | 0 | 2000 | 2015 | ||||||||||
|
estrogen receptor 1 | 0.355 | 0.897 | 1.00 |
|
group | 0.300 | 14 | 0 | 2008 | 2016 | ||||||||||
|
BRCA1, DNA repair associated | 0.410 | 0.862 | 1.8E-28 |
|
group | 0.300 | 12 | 0 | 1995 | 2017 | ||||||||||
|
colony stimulating factor 3 | 0.421 | 0.828 | 0.33 |
|
group | 0.300 | 8 | 0 | 1993 | 2006 | ||||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.341 | 0.897 | 1.00 |
|
group | 0.300 | 8 | 0 | 2009 | 2015 | ||||||||||
|
cyclin D1 | 0.365 | 0.828 | 0.90 |
|
group | 0.300 | 6 | 0 | 2003 | 2014 | ||||||||||
|
epidermal growth factor receptor | 0.325 | 0.862 | 0.50 |
|
group | 0.300 | 6 | 0 | 2006 | 2013 | ||||||||||
|
tumor protein p53 | 0.251 | 0.897 | 0.17 |
|
group | 0.500 | 5 | 0 | 2002 | 2016 | ||||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.338 | 0.897 | 1.00 |
|
group | 0.300 | 5 | 0 | 2006 | 2009 | ||||||||||
|
superoxide dismutase 2 | 0.396 | 0.897 | 0.16 |
|
group | 0.300 | 4 | 0 | 2008 | 2011 | ||||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.482 | 0.690 | 8.6E-06 |
|
group | 0.300 | 4 | 0 | 2002 | 2017 | ||||||||||
|
DNA topoisomerase II alpha | 0.542 | 0.621 | 1.00 |
|
group | 0.300 | 4 | 0 | 2002 | 2012 | ||||||||||
|
HRas proto-oncogene, GTPase | 0.404 | 0.828 | 8.7E-02 |
|
group | 0.300 | 4 | 0 | 2002 | 2009 | ||||||||||
|
vimentin | 0.432 | 0.793 | 0.78 |
|
group | 0.300 | 4 | 0 | 2011 | 2017 | ||||||||||
|
phosphatase and tensin homolog | 0.334 | 0.828 | 0.82 |
|
group | 0.300 | 4 | 0 | 2008 | 2010 | ||||||||||
|
caveolin 1 | 0.416 | 0.828 | 7.2E-03 |
|
group | 0.300 | 4 | 0 | 2009 | 2011 | ||||||||||
|
checkpoint kinase 2 | 0.494 | 0.621 | 1.2E-23 |
|
group | 0.300 | 4 | 0 | 2002 | 2009 | ||||||||||
|
cadherin 1 | 0.432 | 0.759 | 0.11 |
|
group | 0.300 | 4 | 0 | 2007 | 2013 | ||||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.611 | 0.552 | 3.6E-15 |
|
group | 0.300 | 4 | 0 | 2013 | 2016 | ||||||||||
|
interleukin 6 | 0.287 | 0.966 | 0.34 |
|
group | 0.300 | 4 | 0 | 2006 | 2009 | ||||||||||
|
tumor necrosis factor | 0.263 | 0.966 | 0.80 |
|
group | 0.300 | 3 | 0 | 2006 | 2009 | ||||||||||
|
BCL2, apoptosis regulator | 0.312 | 0.862 | 0.57 |
|
group | 0.300 | 3 | 0 | 2003 | 2014 | ||||||||||
|
caspase 8 | 0.443 | 0.793 | 2.8E-06 |
|
group | 0.300 | 3 | 0 | 2004 | 2008 | ||||||||||
|
marker of proliferation Ki-67 | 0.475 | 0.655 | 1.0E-27 |
|
group | 0.300 | 3 | 0 | 2005 | 2009 | ||||||||||
|
BRCA2, DNA repair associated | 0.426 | 0.793 | 5.5E-24 |
|
group | 0.300 | 3 | 0 | 2010 | 2017 |